Trials / Sponsors / Zhejiang Anglikang Pharmaceutical Co., Ltd.
Zhejiang Anglikang Pharmaceutical Co., Ltd.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2026-04-01 |
| Suspended | A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors Advance Solid Tumors | Phase 1 | 2025-06-05 |
| Completed | Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults Diabetic Neuropathies, Diabetes Mellitus | Phase 1 | 2024-12-01 |